Suresh Thareja

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Positive Breast Cancer

Molecular Docking

Top Venues

Medical oncology (Northwood, London, England)

Journal of biomolecular structure & dynamics

Current medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, Sonia Malik, Suresh Thareja
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical oncology (Northwood, London, England) 41 (2) (2024)
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, Sonia Malik, Suresh Thareja
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical oncology (Northwood, London, England) 41 (2) (2024)
Khushi Gupta, Pranay Gautre, Avadh Biharee, Yogesh Singh, Umesh Kumar Patil, Sabyasachi Senapati, Suresh Thareja
Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis. Medical oncology (Northwood, London, England) 41 (4) (2024)
Khushi Gupta, Pranay Gautre, Avadh Biharee, Yogesh Singh, Umesh Kumar Patil, Sabyasachi Senapati, Suresh Thareja
Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis. Medical oncology (Northwood, London, England) 41 (4) (2024)
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, Sonia Malik, Suresh Thareja
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical oncology (Northwood, London, England) 41 (2) (2024)
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, Sonia Malik, Suresh Thareja
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical oncology (Northwood, London, England) 41 (2) (2024)
Khushi Gupta, Pranay Gautre, Avadh Biharee, Yogesh Singh, Umesh Kumar Patil, Sabyasachi Senapati, Suresh Thareja
Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis. Medical oncology (Northwood, London, England) 41 (4) (2024)
Kailash Jangid, Bharti Devi, Ashrulochan Sahoo, Vijay Kumar, Ashish Ranjan Dwivedi, Suresh Thareja, Rajnish Kumar, Vinod Kumar
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease. Journal of biomolecular structure & dynamics (2023)
Adarsh Kumar, Jurica Novak, Ankit Kumar Singh, Harshwardhan Singh, Suresh Thareja, Prateek Pathak, Maria A Grishina, Amita Verma, Pradeep Kumar
Virtual screening, structure based pharmacophore mapping, and molecular simulation studies of pyrido[2,3-d]pyrimidines as selective thymidylate synthase inhibitors. Journal of biomolecular structure & dynamics (2023)
Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Neha Bhatia, Suresh Thareja
Elacestrant: a new FDA-approved SERD for the treatment of breast cancer. Medical oncology (Northwood, London, England) 40 (6) (2023)
Rakesh Khator, Avadh Biharee, Neha Bhatia, Kulkarni Swanand Sanjay, Yogesh Singh, Chandrabose Karthikeyan, Akhlesh Kumar Jain, Suresh Thareja
Medicinal Aspects of PTP 1B Inhibitors as Anti-Breast Cancer Agents: An Overview. Current medicinal chemistry (2023)
Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Yogesh Singh, Niraj Kumar, Kulkarni Swanand Sanjay, Satwinder Singh, Suresh Thareja
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors. Journal of biomolecular structure & dynamics (2023)
Neha Bhatia, Suresh Thareja
Elacestrant: a new FDA-approved SERD for the treatment of breast cancer. Medical oncology (Northwood, London, England) 40 (6) (2023)
Neha Bhatia, Suresh Thareja
Elacestrant: a new FDA-approved SERD for the treatment of breast cancer. Medical oncology (Northwood, London, England) 40 (6) (2023)
Avadh Biharee, Arpita Yadav, Kailash Jangid, Yogesh Singh, Kulkarni Swanand Sanjay, Devesh M Sawant, Pradeep Kumar, Suresh Thareja, Akhlesh Kumar Jain
Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. Journal of biomolecular structure & dynamics (2022)
Pooja Ratre, Kulkarni Swanand Sanjay, Sweety Das, Chengyuan Liang, Pradyumna Kumar Mishra, Suresh Thareja
Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview. Medical oncology (Northwood, London, England) 40 (1) (2022)
Yogesh Singh, Kulkarni Swanand Sanjay, Pradeep Kumar, Satwinder Singh, Suresh Thareja
Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors. Journal of biomolecular structure & dynamics (2022)
Yogesh Singh, Shalini Jaswal, Satwinder Singh, Sant Kumar Verma, Suresh Thareja
Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach. Journal of biomolecular structure & dynamics (2022)
Sant Kumar Verma, Suresh Thareja
Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors. PloS one 12 (4) (2017)